Cutting-edge life science company offers high upside cannabis medical product potential. The company aims to disrupt the drug development market by developing evidence-based cannabis products to help combat serious medical conditions
The Next Marijuana Boom Could Be Even Bigger Than The Last
Published: January 18, 2021
That’s because, despite “Big Pharma’s” massive resources and staggering amounts of spending,
no large pharmaceutical company has ever been able to solve the industry’s most critical problem.
Drug development for major pharmaceutical companies can take as long as a decade.and cost hundreds of billions of dollars in research and development.
Yet a small, little-known company – which could become a truly disruptive cannabis player – now appears uniquely positioned to
upend the drug development market by developing evidence-based cannabis products to combat many of the world’s most serious medical conditions.